Edition:
United Kingdom

Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

2.75USD
19 Oct 2018
Change (% chg)

$0.28 (+11.34%)
Prev Close
$2.47
Open
$2.96
Day's High
$3.10
Day's Low
$2.53
Volume
455,932
Avg. Vol
109,434
52-wk High
$5.14
52-wk Low
$1.86

Chart for

About

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat Alzheimer's disease (AD), other central nervous system (CNS) diseases, pain... (more)

Overall

Beta: 1.01
Market Cap(Mil.): $177.54
Shares Outstanding(Mil.): 42.17
Dividend: --
Yield (%): --

Financials

  AVXL.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -0.39 -- --
ROI: -95.21 0.21 14.27
ROE: -95.21 1.17 15.99

BRIEF-Anavex Life Sciences Reports Q2 Loss Per Share Of $0.11

* ANAVEX LIFE SCIENCES REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS

10 May 2018

Earnings vs. Estimates